Quiver Bioscience Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
4
Quiver Bioscience General Information
Description
Developer of a neuroscience research platform designed to accelerate the discovery of therapeutics for central nervous system disorders. The company offers advanced human cellular models, measurement engineering, and artificial intelligence-driven analysis for neuronal activity and drug response, enabling life sciences researchers and pharmaceutical organizations to identify and develop therapeutics for chronic pain and neurodevelopmental disorders.
Contact Information
Website
www.quiverbioscience.comCorporate Office
- 150 Cambridge Park Drive
- 5th Floor
- Cambridge, MA 02140
- United States
Corporate Office
- 150 Cambridge Park Drive
- 5th Floor
- Cambridge, MA 02140
- United States
Quiver Bioscience Timeline
Quiver Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Later Stage VC | 21-Oct-2026 | $3M | Completed | Pre-Clinical Trials | ||
| 19. Grant | 01-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 18. Later Stage VC | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 17. Buyout/LBO | 05-Jul-2023 | Completed | Pre-Clinical Trials | |||
| 16. Grant | 01-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 15. Grant | 20-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 14. Later Stage VC (Series A1) | 31-Mar-2021 | Completed | Pre-Clinical Trials | |||
| 13. Grant | 30-Sep-2020 | Completed | Startup | |||
| 12. Debt - PPP | 09-Apr-2020 | $1.29M | $31.2M | Completed | Startup | |
| 11. Later Stage VC (Series B) | 14-Feb-2020 | $21.2M | $31.2M | Completed | Startup |
Quiver Bioscience Comparisons
Industry
Financing
Details
Quiver Bioscience Competitors (3)
One of Quiver Bioscience’s 3 competitors is insitro, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| insitro | Venture Capital-Backed | South San Francisco, CA | ||||
| Stoke Therapeutics | Formerly VC-backed | Bedford, MA | ||||
| Wave Therapeutics | Venture Capital-Backed | Nashville, IN |
Quiver Bioscience Patents
Quiver Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025507683-A | Therapeutic agents for syngap haploinsufficiency | Pending | 24-Feb-2022 | ||
| WO-2023163801-A1 | Therapeutics for syngap haploinsufficiency | Inactive | 24-Feb-2022 | ||
| CA-3233095-A1 | Therapeutics for haploinsufficiency conditions | Pending | 23-Sep-2021 | ||
| WO-2023049800-A1 | Therapeutics for haploinsufficiency conditions | Inactive | 23-Sep-2021 | ||
| JP-2024534574-A | Treatment for haploinsufficient conditions | Pending | 23-Sep-2021 | C12N15/113 |
Quiver Bioscience Signals
Quiver Bioscience Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Porta (Beverages) | Corporation | |||
| Pimlico Pond Investments | Family Office | Minority | ||
| Exponential Capital (Atlanta) | Venture Capital | Majority | ||
| National Institutes of Neurological Disorders and Stroke | Government |
Quiver Bioscience Acquisitions (1)
Quiver Bioscience’s most recent deal was a Merger/Acquisition with Claritas Genomics. The deal was made on 09-Feb-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Claritas Genomics | 09-Feb-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Quiver Bioscience FAQs
-
When was Quiver Bioscience founded?
Quiver Bioscience was founded in 2013.
-
Where is Quiver Bioscience headquartered?
Quiver Bioscience is headquartered in Cambridge, MA.
-
What is the size of Quiver Bioscience?
Quiver Bioscience has 26 total employees.
-
What industry is Quiver Bioscience in?
Quiver Bioscience’s primary industry is Drug Discovery.
-
Is Quiver Bioscience a private or public company?
Quiver Bioscience is a Private company.
-
What is Quiver Bioscience’s current revenue?
The current revenue for Quiver Bioscience is .
-
How much funding has Quiver Bioscience raised over time?
Quiver Bioscience has raised $3M.
-
Who are Quiver Bioscience’s investors?
Porta (Beverages), Pimlico Pond Investments, Exponential Capital (Atlanta), and National Institutes of Neurological Disorders and Stroke have invested in Quiver Bioscience.
-
Who are Quiver Bioscience’s competitors?
insitro, Stoke Therapeutics, and Wave Therapeutics are competitors of Quiver Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process